98 related articles for article (PubMed ID: 23809011)
1. SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients.
Sonis S; Antin J; Tedaldi M; Alterovitz G
Oral Dis; 2013 Oct; 19(7):721-7. PubMed ID: 23809011
[TBL] [Abstract][Full Text] [Related]
2. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
Grazziutti ML; Dong L; Miceli MH; Krishna SG; Kiwan E; Syed N; Fassas A; van Rhee F; Klaus H; Barlogie B; Anaissie EJ
Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
[TBL] [Abstract][Full Text] [Related]
3. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation.
Fall-Dickson JM; Ramsay ES; Castro K; Woltz P; Sportés C
Clin Ther; 2007; 29 Suppl():2547-61. PubMed ID: 18164921
[TBL] [Abstract][Full Text] [Related]
4. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
[TBL] [Abstract][Full Text] [Related]
5. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.
Bezinelli LM; de Paula Eduardo F; da Graça Lopes RM; Biazevic MG; de Paula Eduardo C; Correa L; Hamerschlak N; Michel-Crosato E
Hematol Oncol; 2014 Mar; 32(1):31-9. PubMed ID: 23625880
[TBL] [Abstract][Full Text] [Related]
7. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
[TBL] [Abstract][Full Text] [Related]
8. Use of sodium hyaluronate and synthetic amino acid precursors of collagen for the symptomatic treatment of mucositis in patients undergoing haematopoietic stem cell transplants.
Ruggiero T; Pol R; Camisassa D; Arata V; Martino I; Giaccone L; Carossa S
J Biol Regul Homeost Agents; 2016; 30(3):889-894. PubMed ID: 27655517
[TBL] [Abstract][Full Text] [Related]
9. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
[TBL] [Abstract][Full Text] [Related]
11. Prospective longitudinal analysis of clinical and immunological risk factors associated with oral and gastrointestinal mucositis following autologous stem cell transplant in adults.
Wong SP; Tan SM; Lee CS; Law KB; Lim YAL; Rajasuriar R
Support Care Cancer; 2023 Jul; 31(8):494. PubMed ID: 37498423
[TBL] [Abstract][Full Text] [Related]
12. Effect of salivary stimulation therapies on salivary flow and chemotherapy-induced mucositis: a preliminary study.
Pimenta Amaral TM; Campos CC; Moreira dos Santos TP; Leles CR; Teixeira AL; Teixeira MM; Bittencourt H; Silva TA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):628-37. PubMed ID: 22668621
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of an animal model of oral mucositis induced by conditioning regimen of haematopoietic stem cell transplantation].
Chen XB; Wang X; Tong XZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Nov; 42(11):672-6. PubMed ID: 18307925
[TBL] [Abstract][Full Text] [Related]
14. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
[TBL] [Abstract][Full Text] [Related]
15. GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis.
Coleman EA; Lee JY; Erickson SW; Goodwin JA; Sanathkumar N; Raj VR; Zhou D; McKelvey KD; Apewokin S; Stephens O; Enderlin CA; Vangsted AJ; Reed PJ; Anaissie EJ
Support Care Cancer; 2015 Mar; 23(3):841-9. PubMed ID: 25218607
[TBL] [Abstract][Full Text] [Related]
16. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT--results of a multicentre study.
Vagliano L; Feraut C; Gobetto G; Trunfio A; Errico A; Campani V; Costazza G; Mega A; Matozzo V; Berni M; Alberani F; Banfi MM; Martinelli L; Munaron S; Orlando L; Lubiato L; Leanza S; Guerrato R; Rossetti A; Messina M; Barzetti L; Satta G; Dimonte V
Bone Marrow Transplant; 2011 May; 46(5):727-32. PubMed ID: 20818449
[TBL] [Abstract][Full Text] [Related]
17. The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review.
Antunes HS; Ferreira EM; de Matos VD; Pinheiro CT; Ferreira CG
Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E189-92. PubMed ID: 18305441
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
[TBL] [Abstract][Full Text] [Related]
19. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: a retrospective study.
Bardellini E; Schumacher F; Conti G; Porta F; Campus G; Majorana A
Pediatr Transplant; 2013 Aug; 17(5):492-7. PubMed ID: 23750582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
